Seroprevalence of Pandemic A(H1N1) pmd09 Virus Antibodies in Mexican Health Care Workers Before and After Vaccination

被引：4

作者：

Aguilar-Madrid, Guadalupe ^{[1
]}

Arturo Castelan-Vega, Juan ^{[2
,3
]}

Arturo Juarez-Perez, Cuauhtemoc ^{[1
]}

Maria Ribas-Aparicio, Rosa ^{[2
,3
]}

Estrada-Garcia, Iris ^{[2
,3
]}

Baltierra-Jasso, Laura ^{[2
,3
]}

Cervantes-Servin, Nicte ^{[4
]}

Mendez-Ortega, Vanessa ^{[2
,3
]}

Haro-Garcia, Luis C. ^{[5
]}

Raul Sanchez-Roman, Francisco ^{[6
]}

Ortiz-Navarrete, Vianney ^{[7
]}

Fabila-Castillo, Luis H. ^{[2
,3
]}

Magana-Hernandez, Anastasia ^{[2
,3
]}

Chavez-Negrete, Adolfo ^{[8
]}

Abdel Salamanca-Gomez, Fabio ^{[9
]}

Jimenez-Alberto, Alicia ^{[2
,3
]}

机构：

[1] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Occupat Hlth Res Unit, Mexico City, DF, Mexico

[2] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Mexico City, DF, Mexico

[3] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Immunol, Mexico City, DF, Mexico

[4] Hosp Infect Dis, Inst Mexicano Seguro Social, La Raza Natl Med Ctr, Immunol Res Unit, Mexico City, DF, Mexico

[5] Univ Autonoma Ciudad Mexico, Promoc Salud, Acad Salud Comunitaria, Mexico City, DF, Mexico

[6] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Dept Workplace Hlth, Disabil Div, Mexico City, DF, Mexico

[7] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Mol Biomed, Mexico City, DF, Mexico

[8] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Specialties Hosp, Educ & Res, Mexico City, DF, Mexico

[9] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Coordinac Invest Salud, Mexico City, DF, Mexico

来源：

ARCHIVES OF MEDICAL RESEARCH | 2015年 / 46卷 / 02期

关键词：

Influenza A(H1N1)pdm09; Seroprevalence; Vaccination; Health care workers; Retroviral pseudotypes; H1N1; 2009; INFLUENZA; HOSPITAL STAFF;

D O I：

10.1016/j.arcmed.2015.03.001

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Background and Aims. In April 2009, a new strain of influenza A(H1N1) was identified in Mexico and in the U.S. In June 2009, WHO declared this a pandemic. Health care workers constituted a risk group for their close contact with infected individuals. The aim was to estimate seropositivity for A(H1N1)pdm09 in health staff at the Instituto Mexican del Seguro Social. Methods. A two-stage cross-sectional study, before and after vaccination in the same workers, was performed on a random sample of health-care workers. A socio-occupational questionnaire was applied and serum antibodies against influenza A(H1N1)pdm09 were determined through neutralization of retroviral pseudotypes; two logistic regression models for both were constructed. Results. The average (median/mean) age of 1378 participants from 13 work centers was 41.7 years and 68.7% (947) were women. Seroprevalence for the first stage was 26.5% (365) (7.4-43%) vs. 20.8% (11) in a control group from the blood bank; for the second stage, the vaccinated group was 33% (215) (18.2-47%) and 27% (196) (11.6-50%) for the unvaccinated group. In regression models, seropositivity was associated with occupational exposure to suspected influenza infected patients, being physicians, and being vaccinated. Conclusions. Seropositivity against pandemic virus is similar to what was reported, both for vaccinated (2.8-40.9%) and unvaccinated (18.8-64.7%). Low seroprevalence in the vaccinated group indicates that between 67% and 73% were susceptible to infection. Given the relatively low vaccine-induced seropositivity, it is imperative to increase, hygiene and safety for health staff and at-risk populations, and strengthen epidemiological surveillance. (C) 2015 IMSS. Published by Elsevier Inc.

引用

页码：154 / 163

页数：10

共 27 条

[1] Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses [J].